Abstract
Some aspects of glucose homeostasis and energy balance are regulated differently in males and females. This review discusses the most fundamental gender differences in diabetes and obesity, including the prevalence of impaired fasting glucose and impaired glucose tolerance, the prevalence and incidence of type 2 and type 1 diabetes, as well as the prevalence of metabolic syndrome and obesity. These gender-specific differences in glucose homeostasis and energy balance represent a source of factors that should be studied to develop gender-based therapeutic avenues for diabetes.
This is a preview of subscription content, log in via an institution.
References
Aguilar, M., Bhuket, T., Torres, S., Liu, B., & Wong, R. J. (2015). Prevalence of the metabolic syndrome in the United States, 2003–2012. JAMA, 313, 1973–1974.
Al-Lawati, J. A., Mohammed, A. J., Al-Hinai, H. Q., & Jousilahti, P. (2003). Prevalence of the metabolic syndrome among Omani adults. Diabetes Care, 26, 1781–1785.
Basu, R., Dalla Man, C., Campioni, M., Basu, A., Klee, G., Toffolo, G., Cobelli, C., & Rizza, R. A. (2006). Effects of age and sex on postprandial glucose metabolism: Differences in glucose turnover, insulin secretion, insulin action, and hepatic insulin extraction. Diabetes, 55, 2001–2014.
Blohme, G., Nystrom, L., Arnqvist, H. J., Lithner, F., Littorin, B., Olsson, P. O., Schersten, B., Wibell, L., & Ostman, J. (1992). Male predominance of type 1 (insulin-dependent) diabetes mellitus in young adults: Results from a 5-year prospective nationwide study of the 15–34-year age group in Sweden. Diabetologia, 35, 56–62.
Ford, E. S., Giles, W. H., & Mokdad, A. H. (2004). Increasing prevalence of the metabolic syndrome among U.S. Adults. Diabetes Care, 27, 2444–2449.
Frias, J. P., Macaraeg, G. B., Ofrecio, J., Yu, J. G., Olefsky, J. M., & Kruszynska, Y. T. (2001). Decreased susceptibility to fatty acid-induced peripheral tissue insulin resistance in women. Diabetes, 50, 1344–1350.
Gale, E. A., & Gillespie, K. M. (2001). Diabetes and gender. Diabetologia, 44, 3–15.
Glumer, C., Jorgensen, T., & Borch-Johnsen, K. (2003). Prevalences of diabetes and impaired glucose regulation in a Danish population: The Inter99 study. Diabetes Care, 26, 2335–2340.
Gourdy, P., Bourgeois, E. A., Levescot, A., Pham, L., Riant, E., Ahui, M. L., Damotte, D., Gombert, J. M., Bayard, F., Ohlsson, C., Arnal, J. F., & Herbelin, A. (2016). Estrogen therapy delays autoimmune diabetes and promotes the protective efficiency of natural killer T-cell activation in female nonobese diabetic mice. Endocrinology, 157, 258–267.
Gu, D., Reynolds, K., Wu, X., Chen, J., Duan, X., Reynolds, R. F., Whelton, P. K., & He, J. (2005). Prevalence of the metabolic syndrome and overweight among adults in China. Lancet, 365, 1398–1405.
Gupta, R., Deedwania, P. C., Gupta, A., Rastogi, S., Panwar, R. B., & Kothari, K. (2004). Prevalence of metabolic syndrome in an Indian urban population. International Journal of Cardiology, 97, 257–261.
Kelly, T., Yang, W., Chen, C. S., Reynolds, K., & He, J. (2008). Global burden of obesity in 2005 and projections to 2030. International Journal of Obesity, 32, 1431–1437.
Louet, J. F., Smith, S. B., Gautier, J. F., Molokhia, M., Virally, M. L., Kevorkian, J. P., Guillausseau, P. J., Vexiau, P., Charpentier, G., German, M. S., Vaisse, C., Urbanek, M., & Mauvais-Jarvis, F. (2008). Gender and neurogenin3 influence the pathogenesis of ketosis-prone diabetes. Diabetes, Obesity & Metabolism, 10, 912–920.
Martinez, D., Castro, A., Merino, P. M., Lopez, P., Lardone, M. C., Iniguez, G., Cassorla, F., & Codner, E. (2016). Oestrogen activity of the serum in adolescents with Type 1 diabetes. Diabetic Medicine, 33, 1366–1373.
Mauvais-Jarvis, F. (2016). Role of sex steroids in beta cell function, growth, and survival. Trends in Endocrinology and Metabolism, 27, 844–855.
Mauvais-Jarvis, F., Manson, J. E., Stevenson, J. C., & Fonseca, V. A. (2017). Menopausal hormone therapy and type 2 diabetes prevention: Evidence, mechanisms and clinical implications. Endocrine Reviews, 38, 173–188.
Mauvais-Jarvis, F., Sobngwi, E., Porcher, R., Riveline, J. P., Kevorkian, J. P., Vaisse, C., Charpentier, G., Guillausseau, P. J., Vexiau, P., & Gautier, J. F. (2004). Ketosis-prone type 2 diabetes in patients of sub-Saharan African origin: Clinical pathophysiology and natural history of beta-cell dysfunction and insulin resistance. Diabetes, 53, 645–653.
Menke, A., Casagrande, S., Geiss, L., & Cowie, C. C. (2015). Prevalence of and trends in diabetes among adults in the United States, 1988–2012. JAMA, 314, 1021–1029.
Mozumdar, A., & Liguori, G. (2011). Persistent increase of prevalence of metabolic syndrome among U.S. adults: NHANES III to NHANES 1999–2006. Diabetes Care, 34, 216–219.
Nuutila, P., Knuuti, M. J., Maki, M., Laine, H., Ruotsalainen, U., Teras, M., Haaparanta, M., Solin, O., & Yki-Jarvinen, H. (1995). Gender and insulin sensitivity in the heart and in skeletal muscles. Studies using positron emission tomography. Diabetes, 44, 31–36.
Nystrom, L., Dahlquist, G., Ostman, J., Wall, S., Arnqvist, H., Blohme, G., Lithner, F., Littorin, B., Schersten, B., & Wibell, L. (1992). Risk of developing insulin-dependent diabetes mellitus (IDDM) before 35 years of age: Indications of climatological determinants for age at onset. International Journal of Epidemiology, 21, 352–358.
Samuelsson, U., Lindblad, B., Carlsson, A., Forsander, G., Ivarsson, S., Kockum, I., Lernmark, A., Marcus, C., & Ludvigsson, J. (2013). Residual beta cell function at diagnosis of type 1 diabetes in children and adolescents varies with gender and season. Diabetes/Metabolism Research and Reviews, 29, 85–89.
Sicree, R. A., Zimmet, P. Z., Dunstan, D. W., Cameron, A. J., Welborn, T. A., & Shaw, J. E. (2008). Differences in height explain gender differences in the response to the oral glucose tolerance test- the AusDiab study. Diabetic Medicine, 25, 296–302.
Tiano, J. P., & Mauvais-Jarvis, F. (2012). Importance of oestrogen receptors to preserve functional beta-cell mass in diabetes. Nature Reviews Endocrinology, 8, 342–351.
Umpierrez, G. E., Smiley, D., & Kitabchi, A. E. (2006). Narrative review: Ketosis-prone type 2 diabetes mellitus. Annals of Internal Medicine, 144, 350–357.
Van Genugten, R. E., Utzschneider, K. M., Tong, J., Gerchman, F., Zraika, S., Udayasankar, J., Boyko, E. J., Fujimoto, W. Y., & Kahn, S. E. (2006). Effects of sex and hormone replacement therapy use on the prevalence of isolated impaired fasting glucose and isolated impaired glucose tolerance in subjects with a family history of type 2 diabetes. Diabetes, 55, 3529–3535.
Wild, S., Roglic, G., Green, A., Sicree, R., & King, H. (2004). Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care, 27, 1047–1053.
Williams, J. W., Zimmet, P. Z., Shaw, J. E., De Courten, M. P., Cameron, A. J., Chitson, P., Tuomilehto, J., & Alberti, K. G. (2003). Gender differences in the prevalence of impaired fasting glycaemia and impaired glucose tolerance in Mauritius. Does sex matter? Diabetic Medicine, 20, 915–920.
Acknowledgments
This work was supported by grants from the National Institutes of Health (DK074970, DK107444), the American Diabetes Association (7-13-BS-101), and a VA Merit Review Award (BX003725).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Mauvais-Jarvis, F. (2017). Epidemiology of Gender Differences in Diabetes and Obesity. In: Mauvais-Jarvis, F. (eds) Sex and Gender Factors Affecting Metabolic Homeostasis, Diabetes and Obesity. Advances in Experimental Medicine and Biology, vol 1043. Springer, Cham. https://doi.org/10.1007/978-3-319-70178-3_1
Download citation
DOI: https://doi.org/10.1007/978-3-319-70178-3_1
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-70177-6
Online ISBN: 978-3-319-70178-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)